PE20070113A1 - Derivados de quinolina y quinazolina como inhibidores de tirosinquinasas flt3 y trkb - Google Patents
Derivados de quinolina y quinazolina como inhibidores de tirosinquinasas flt3 y trkbInfo
- Publication number
- PE20070113A1 PE20070113A1 PE2006000650A PE2006000650A PE20070113A1 PE 20070113 A1 PE20070113 A1 PE 20070113A1 PE 2006000650 A PE2006000650 A PE 2006000650A PE 2006000650 A PE2006000650 A PE 2006000650A PE 20070113 A1 PE20070113 A1 PE 20070113A1
- Authority
- PE
- Peru
- Prior art keywords
- dimetoxy
- quinazolin
- piperidin
- trkb
- flt3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE q ES 0-2; p ES 0-1; Q ES NH, N(ALQUILO), O, O UN ENLACE DIRECTO; X ES N, C-CN, CH; Z ES NH, N(ALQUILO), CH2; B ES CICLOALQUILO, HETEROARILO, BENZOFUSIONADO DE 9-10 MIEMBROS, ENTRE OTROS; R1 Y R2 SON CADA UNO DE PREFERENCIA H, METOXI, 2-METOXI-ETOXI, ENTRE OTROS; R3 ES ALQUILO, ALCOXI, HALOGENO, NITRO, CICLOALQUILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: ESTER 1-(6,7-DIMETOXI-QUINAZOLIN-4-IL)-PIPERIDIN-4-ILICO DE ACIDO (4-ISOPROPIL-FENIL)-CARBAMICO; 2-[1-(6,7-DIMETOXI-QUINAZOLIN-4-IL)-PIPERIDIN-4-IL]-N-(4-ISOPROPIL-FENIL)-ACETAMIDA; N-[1-(6,7-DIMETOXI-QUINAZOLIN-4-IL)-PIPERIDIN-4-IL]-2-(4-ISOPROPIL-FENIL)-CARBAMICO; ENTRE OTROS. REFERIDA TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DE LA PROTEINA TIROSINA QUINASA, PARTICULARMENTE DE FLT3 (LIGANDO DE TIROSINQUINASA 3) Y/O TrkB (TIROSINQUINASA RECEPTORAS DE TIPO B), UTILES EN EL TRATAMIENTO DE CANCER Y OTROS DESORDENES PROLIFERATIVOS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68938205P | 2005-06-10 | 2005-06-10 | |
US74732106P | 2006-05-16 | 2006-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070113A1 true PE20070113A1 (es) | 2007-02-09 |
Family
ID=37101582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000650A PE20070113A1 (es) | 2005-06-10 | 2006-06-09 | Derivados de quinolina y quinazolina como inhibidores de tirosinquinasas flt3 y trkb |
Country Status (17)
Country | Link |
---|---|
US (1) | US20070004763A1 (es) |
EP (1) | EP1899319A2 (es) |
JP (1) | JP2008543762A (es) |
KR (1) | KR20080028913A (es) |
AR (1) | AR057062A1 (es) |
AU (1) | AU2006258059A1 (es) |
BR (1) | BRPI0611621A2 (es) |
CA (1) | CA2611378A1 (es) |
CR (1) | CR9647A (es) |
EA (1) | EA200800014A1 (es) |
EC (1) | ECSP077998A (es) |
GT (1) | GT200600254A (es) |
IL (1) | IL187685A0 (es) |
NO (1) | NO20080168L (es) |
PE (1) | PE20070113A1 (es) |
TW (1) | TW200716598A (es) |
WO (1) | WO2006135649A2 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2066642A1 (en) * | 2006-09-25 | 2009-06-10 | Arete Therapeutics, INC. | Soluble epoxide hydrolase inhibitors |
PE20090717A1 (es) | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
AR102537A1 (es) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | Agentes inmunomoduladores |
JP6903585B2 (ja) * | 2015-03-13 | 2021-07-14 | レスバーロジックス コーポレイション | 補体関連疾患の治療のための組成物および治療方法 |
WO2017107089A1 (en) | 2015-12-23 | 2017-06-29 | Merck Sharp & Dohme Corp. | 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor |
EP3394061B1 (en) | 2015-12-23 | 2020-03-11 | Merck Sharp & Dohme Corp. | 6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the m4 muscarinic acetylcholine receptor |
CN109311816A (zh) * | 2016-05-04 | 2019-02-05 | 百时美施贵宝公司 | 吲哚胺2,3-双加氧酶的抑制剂及其使用方法 |
EP3496715B1 (en) | 2016-08-15 | 2021-11-03 | Merck Sharp & Dohme Corp. | Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease |
US10414774B2 (en) | 2016-08-15 | 2019-09-17 | Merck Sharp & Dohme Corp. | Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease |
WO2018112842A1 (en) | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor |
WO2018112843A1 (en) | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor |
WO2018112840A1 (en) | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor |
WO2019000236A1 (en) | 2017-06-27 | 2019-01-03 | Merck Sharp & Dohme Corp. | ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR |
WO2019000238A1 (en) | 2017-06-27 | 2019-01-03 | Merck Sharp & Dohme Corp. | 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR |
WO2019000237A1 (en) | 2017-06-27 | 2019-01-03 | Merck Sharp & Dohme Corp. | ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR |
CN111372587B (zh) | 2017-09-08 | 2024-01-09 | 里兰斯坦福初级大学理事会 | Enpp1抑制剂以及它们用于治疗癌症的用途 |
EP3787629A4 (en) | 2018-05-02 | 2022-01-05 | Kinnate Biopharma Inc. | INHIBITORS OF CYCLINE-DEPENDENT KINASES |
WO2020006497A1 (en) | 2018-06-29 | 2020-01-02 | Kinnate Biopharma Inc. | Inhibitors of cyclin-dependent kinases |
JPWO2020017569A1 (ja) * | 2018-07-17 | 2021-12-02 | 日本ケミファ株式会社 | T型カルシウムチャネル阻害剤 |
JP2022081710A (ja) * | 2019-03-29 | 2022-06-01 | ユーティアイ リミテッド パートナーシップ | 関節リウマチを治療するためのt型カルシウムチャネル阻害剤の使用 |
US20220226299A1 (en) * | 2019-03-29 | 2022-07-21 | Nippon Chemiphar Co., Ltd. | Use of t-type calcium channel blocker for treating pruritus |
CA3147422A1 (en) * | 2019-07-17 | 2021-01-21 | Kinnate Biopharma Inc. | Inhibitors of cyclin-dependent kinases |
JP2023535096A (ja) * | 2020-07-23 | 2023-08-15 | シトシンラボ セラピューティクス カンパニー, リミテッド | キナーゼ阻害活性を有する化合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT344178B (de) * | 1974-07-25 | 1978-07-10 | Pfizer | Verfahren zur herstellung von neuen chinazolinverbindungen und deren saeureadditionssalzen und optisch aktiven formen |
JP3169188B2 (ja) * | 1991-01-31 | 2001-05-21 | 杏林製薬株式会社 | カルバミン酸誘導体及びその製造方法 |
EP1382603B1 (en) * | 2001-04-26 | 2008-07-23 | Eisai R&D Management Co., Ltd. | Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
MXPA05000081A (es) * | 2002-06-27 | 2005-04-11 | Schering Ag | Quinolinas sustituidas antagonistas del receptor ccr5. |
DK1678166T3 (da) * | 2003-10-14 | 2009-11-09 | Univ Arizona State | Proteinkinaseinhibitorer |
-
2006
- 2006-06-06 US US11/422,355 patent/US20070004763A1/en not_active Abandoned
- 2006-06-07 KR KR1020087000407A patent/KR20080028913A/ko not_active Application Discontinuation
- 2006-06-07 EA EA200800014A patent/EA200800014A1/ru unknown
- 2006-06-07 JP JP2008515893A patent/JP2008543762A/ja not_active Withdrawn
- 2006-06-07 BR BRPI0611621-3A patent/BRPI0611621A2/pt not_active Application Discontinuation
- 2006-06-07 AU AU2006258059A patent/AU2006258059A1/en not_active Abandoned
- 2006-06-07 EP EP06772478A patent/EP1899319A2/en not_active Withdrawn
- 2006-06-07 CA CA002611378A patent/CA2611378A1/en not_active Abandoned
- 2006-06-07 WO PCT/US2006/022195 patent/WO2006135649A2/en active Application Filing
- 2006-06-08 GT GT200600254A patent/GT200600254A/es unknown
- 2006-06-09 PE PE2006000650A patent/PE20070113A1/es not_active Application Discontinuation
- 2006-06-09 AR ARP060102424A patent/AR057062A1/es not_active Application Discontinuation
- 2006-06-09 TW TW095120476A patent/TW200716598A/zh unknown
-
2007
- 2007-11-27 IL IL187685A patent/IL187685A0/en unknown
- 2007-12-10 EC EC2007007998A patent/ECSP077998A/es unknown
-
2008
- 2008-01-09 NO NO20080168A patent/NO20080168L/no not_active Application Discontinuation
- 2008-01-09 CR CR9647A patent/CR9647A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL187685A0 (en) | 2008-08-07 |
TW200716598A (en) | 2007-05-01 |
CR9647A (es) | 2008-09-09 |
AR057062A1 (es) | 2007-11-14 |
WO2006135649A3 (en) | 2007-02-15 |
GT200600254A (es) | 2007-01-12 |
JP2008543762A (ja) | 2008-12-04 |
AU2006258059A1 (en) | 2006-12-21 |
EA200800014A1 (ru) | 2008-06-30 |
WO2006135649A2 (en) | 2006-12-21 |
KR20080028913A (ko) | 2008-04-02 |
NO20080168L (no) | 2008-03-07 |
US20070004763A1 (en) | 2007-01-04 |
BRPI0611621A2 (pt) | 2010-09-21 |
EP1899319A2 (en) | 2008-03-19 |
CA2611378A1 (en) | 2006-12-21 |
ECSP077998A (es) | 2008-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070113A1 (es) | Derivados de quinolina y quinazolina como inhibidores de tirosinquinasas flt3 y trkb | |
PE20040647A1 (es) | Inhibidores de cinasas de tirosina | |
PE20070076A1 (es) | Aminopirimidinas como moduladores de quinasas | |
EA200800018A1 (ru) | Аминопиримидины в качестве модуляторов киназы | |
PE20080404A1 (es) | Derivados bencil-amino-piperidina como inhibidores de cetp | |
PE20051171A1 (es) | Inhibidores de proteina quinasas con estructura de 3-quinolincarbonitrilo | |
PE20060573A1 (es) | Derivados de urea ciclicos sustituidos como inhibidores de proteinas quinasas | |
PE20091243A1 (es) | Compuesto heterociclico fusionado | |
PE20091955A1 (es) | Derivados de quinoxalin- y quinolin-carboxamida | |
PE20010741A1 (es) | Derivados de piperazina como antagonistas de taquicininas | |
PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina | |
GT200600105A (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos. | |
PE20070070A1 (es) | Derivados de tienopiridina y tienopirimidina como agentes moduladores de tirosinquinasa | |
EA200700047A1 (ru) | Новые алкильные производные в качестве метаботропных рецепторов глутамата | |
PE20060736A1 (es) | DERIVADOS DE PIRROL COMO ANTAGONISTAS DE CRTh2 | |
ATE557014T1 (de) | Neue substituierte indolin-2-on-derivate und ihre verwendung als p38-mitogenaktivierte kinasehemmer | |
EA200700142A1 (ru) | Замещенные гетероциклом циклические производные мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназы | |
PE20090982A1 (es) | Derivados de piperidina como inhibidores de la proteina de transferencia de colesteril-ester (cetp) | |
AR053109A1 (es) | DERIVADOS DE PIPERIDINA Y PIPERAZINA, UN METODO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU USO EN LA ELABORACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR EL RECEPTOR DE QUIMIOQUINA CCR2. | |
PE20060770A1 (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1 | |
PE20081351A1 (es) | Derivados de quinazolina como agentes anticancerigenos | |
PE20090876A1 (es) | Nuevos derivados de 6-aril/heteroalquiloxi benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de cmet | |
AR051471A1 (es) | Derivados de sulfonamida como moduladores del receptor de glugocorticoides | |
PE20070069A1 (es) | Piperazin-piperidinas como antagonistas y agonistas del receptor 5-ht1a | |
TW200716599A (en) | Alkylquinoline and alkylquinazoline kinase modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |